HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors

Overexpression of the human epidermal growth factor receptor (HER)-2 oncogenic receptor tyrosine kinase, which occurs in 25% of breast cancers, portends poor clinical outcome and consequently represents an attractive target for therapeutic intervention. Small molecule tyrosine kinase inhibitors that...

Descripción completa

Detalles Bibliográficos
Autores principales: Spector, Neil, Xia, Wenle, El-Hariry, Iman, Yarden, Yossi, Bacus, Sarah
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868927/
http://dx.doi.org/10.1186/bcr1652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868927/
http://dx.doi.org/10.1186/bcr1652

Ejemplares similares